Cox-2 inhibition and chemoradiation for squamous cell carcinoma of the head and neck

被引:0
|
作者
Spencer, S.
Nabell, L.
Bonner, J.
Peters, G.
Carroll, W. L.
Meredith, R.
Clemons, L.
Ove, R.
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] E Carolina Univ, Brody Sch Med, Greenville, NC USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.6065
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6065
引用
收藏
页数:1
相关论文
共 50 条
  • [41] FAM175B suppresses apoptosis by the inhibition of COX-2 in esophageal squamous cell carcinoma
    Yu, Yang
    Zhao, Yu
    Zhu, Shengtao
    Min, Li
    Zhang, Shutian
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 323 - 323
  • [42] Significance of COX-2 expression in human esophageal squamous cell carcinoma
    Zhi, Huiying
    Wang, Lin
    Zhang, Jian
    Zhou, Chuannong
    Ding, Fang
    Luo, Aiping
    Wu, Min
    Zhan, Qimin
    Liu, Zhihua
    CARCINOGENESIS, 2006, 27 (06) : 1214 - 1221
  • [43] Is a Routine Neck Dissection Necessary Following Chemoradiation Therapy for N2 Head-and-Neck Squamous Cell Carcinoma?
    Karakaya, E.
    Yetmen, O.
    Oksuz, D. Colpan
    Dyker, K.
    Coyle, C.
    Sen, M.
    Prestwich, R. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S470 - S470
  • [44] COX-2 inhibition in combination with preoperative chemoradiation for CA esophagus
    Kwong, D. L.
    Law, S. Y.
    Tong, D. K.
    Wong, K. H.
    Nicholls, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition
    Stephan Lang
    Sanjay Tiwari
    Michaela Andratschke
    Iren Loehr
    Lina Lauffer
    Christoph Bergmann
    Brigitte Mack
    Annette Lebeau
    Andreas Moosmann
    Theresa L. Whiteside
    Reinhard Zeidler
    Cancer Immunology, Immunotherapy, 2007, 56 : 1645 - 1652
  • [46] Immune restoration in head and neck cancer patients after in vivo COX-2 inhibition
    Lang, Stephan
    Tiwari, Sanjay
    Andratschke, Michaela
    Loehr, Iren
    Lauffer, Lina
    Bergmann, Christoph
    Mack, Brigitte
    Lebeau, Annette
    Moosmann, Andreas
    Whiteside, Theresa L.
    Zeidler, Reinhard
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (10) : 1645 - 1652
  • [47] EXTENT OF NECK DISSECTION REQUIRED AFTER CONCURRENT CHEMORADIATION FOR STAGE IV HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Cannady, Steven B.
    Lee, Walter T.
    Scharpf, Joseph
    Lorenz, Robert R.
    Wood, Benjamin G.
    Strome, Marshall
    Lavertu, Pierre
    Esclamado, Ramon M.
    Saxton, Jerrold P.
    Adelstein, David J.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (03): : 348 - 356
  • [48] OUTCOME WITH NECK DISSECTION AFTER CHEMORADIATION FOR N3 HEAD-AND-NECK SQUAMOUS CELL CARCINOMA
    Igidbashian, Levon
    Fortin, Bernard
    Guertin, Louis
    Soulieres, Denis
    Coulombe, Genevieve
    Belair, Manon
    Charpentier, Danielle
    Tabet, Jean-Claude
    Nguyen-Tan, Phuc Felix
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (02): : 414 - 420
  • [49] Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment
    McCusker, Michael G.
    Mehra, Ranee
    Amr, Sania
    Taylor, Rodney J.
    Cullen, Kevin J.
    Goloubeva, Olga G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (03): : 749 - 759
  • [50] Chemoradiation and local recurrence of head and neck squamous cell carcinoma and the risk of carotid artery blowout
    Jacobi, Christian
    Gahleitner, Constanze
    Bier, Henning
    Knopf, Andreas
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (09): : 3073 - 3079